Stock Comparison

REGN vs RVMD

Regeneron Pharmaceuticals Inc and Revolution Medicines Inc side by side — valuation, profitability, growth and risk.

REGN

Regeneron Pharmaceuticals Inc

Healthcare

RVMD

Revolution Medicines Inc

Healthcare

Valuation

Market Cap

$66.35B

$38.71B

P/E (TTM)

15.5

—

Forward P/E

14.1

—

Price/Sales

4.5

9,035.1

Price/Book

2.1

25.8

EV/EBITDA

10.5

-9.7

Dividend Yield

0.58%

—

Profitability

Net Margin

29.60%

0.00%

Operating Margin

20.70%

0.00%

Return on Equity

14.50%

-76.70%

Return on Assets

6.13%

-37.50%

Growth (YoY)

Revenue Growth

19.00%

-95.20%

Earnings Growth

-7.20%

0.00%

Price & Risk

Beta

0.2

1.4

52-Week High

$818.90

$184.39

52-Week Low

$516.07

$34.00

Analyst Target

$833.31

$188.57

Compare REGN and RVMD your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.